Regenxbio (RGNX) EBT Margin (2014 - 2026)
Regenxbio (RGNX) posted quarterly EBT Margin of 330.86% for Q4 2025, up 64489.0% year-over-year from N/an in Q4 2024, and up 250.23% quarter-over-quarter from 220.23% in Q3 2025.
Powered by 
Analysis
Regenxbio (RGNX) EBT Margin (2014 - 2026) Analysis & Trends
Regenxbio's EBT Margin history runs 12 years deep, the most recent figure standing at 330.86% for Q4 2025.
- In Q4 2025, EBT Margin rose 64489.0% year-over-year to 330.86%; the TTM figure through Dec 2025 stood at 26.03% (up 28240.0% YoY), while the FY2025 annual figure was 342.72%, down 7018.0% from the prior year.
- EBT Margin for Q4 2025 stood at 330.86%, up from 220.23% in the prior quarter.
- The five-year high for EBT Margin was 703.02% in Q4 2022, with the low at 481.95% in Q1 2024.
- The 5-year median for EBT Margin is 254.98% (2021), against an average of 174.58%.
- The sharpest annual moves came in 2023 and 2025: EBT Margin sank 98650 bps in 2023, then soared 64489 bps in 2025.
- Regenxbio's EBT Margin stood at 77.12% in 2021, then soared by 812 bps to 703.02% in 2022, then tumbled by 140 bps to 283.48% in 2023, then dropped by 11 bps to 314.04% in 2024, then surged by 205 bps to 330.86% in 2025.
- Business Quant data shows RGNX's EBT Margin at 330.86% in Q4 2025, 220.23% in Q3 2025, and 331.91% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 10 | Regenxbio | 472.74 Mn | 367.22 Mn | - | 21.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.01% |
| Dec 31, 2025 | -221.40% |
| Sep 30, 2025 | -208.39% |
| Jun 30, 2025 | -331.91% |
| Mar 31, 2025 | 6.81% |
| Dec 31, 2024 | -241.68% |
| Sep 30, 2024 | -246.40% |
| Jun 30, 2024 | -237.80% |
| Mar 31, 2024 | -405.63% |
| Dec 31, 2023 | -283.80% |
| Sep 30, 2023 | -213.97% |
| Jun 30, 2023 | -360.72% |
| Mar 31, 2023 | -348.40% |
| Dec 31, 2022 | -191.35% |
| Sep 30, 2022 | -284.72% |
| Jun 30, 2022 | -208.82% |
| Mar 31, 2022 | -345.50% |
| Dec 31, 2021 | 77.13% |
| Sep 30, 2021 | -189.79% |
| Jun 30, 2021 | -261.58% |